This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
A screen shows the graph of the Dow after the closing bell at the New York Stock Exchange (NYSE) at Wall Street in New York City on March 17, 2020. Johannes Eiselle/AFP via Getty Images
Wells Fargo analyst Colin Langan upgraded Cerence Inc. from Equal-Weight to Overweight and an $85 price target, down from $91, implying a 15 percent upside.
Langan noted Cerence is down about 50 percent from its high and 34 percent since reporting FY21 results and guiding below consensus for FY22.
